The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 08, 2023

Filed:

Apr. 08, 2021
Applicant:

Universitätsspital Basel, Basel, CH;

Inventors:
Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/48 (2006.01); A61K 31/4045 (2006.01); A61K 31/675 (2006.01); A61P 25/24 (2006.01); G01N 33/68 (2006.01); A61K 31/137 (2006.01);
U.S. Cl.
CPC ...
A61K 31/48 (2013.01); A61K 31/137 (2013.01); A61K 31/4045 (2013.01); A61K 31/675 (2013.01); A61P 25/24 (2018.01); G01N 33/6893 (2013.01); G01N 2800/304 (2013.01); G01N 2800/52 (2013.01);
Abstract

A method of dosing and treating patients with a psychedelic, by administering a psychedelic at a dose of a microdose, minidose, psychedelic dose, good effect dose, ego-dissolution dose, or cardiovascular safe dose, and producing maximum positive subjective acute effects that are known to be associated with more positive long-term outcomes and minimizing negative acute effects. A method of determining a dose of a psychedelic for an individual, by administering a dose of a psychedelic to the individual of a microdose, minidose, psychedelic dose, good effect dose, ego-dissolution dose, or cardiovascular safe dose, determining positive acute effects and negative acute effects in the individual, and adjusting the dose to provide more positive acute effects than negative acute effects in the individual. Methods of treating psychiatric conditions or providing therapy. A method of defining therapeutic doses of a psychedelic in clinical trials. A method of monitoring individuals for depression after treatment with LSD.


Find Patent Forward Citations

Loading…